BRS2(FM3) - Methylation–Membrane Coupling
(Methylation Support for Brain Membrane Building)
1. Mission & Overview
Mission
Connect methylation capacity to membrane phospholipid chemistry so one-carbon nutrition supports the lipid environment the brain depends on.
Overview
Connects methylation capacity to membrane phospholipid chemistry — the bridge between B-vitamin status and the membrane environment the brain relies on. SAMe supply and phosphatidylcholine formation work together to shape omega-3 carriage and membrane integrity.
- Supports neuronal membrane composition and long-chain fat delivery to the brain — Supporting BRS1.
- Links one-carbon and B-vitamin nutrition to membrane signalling competence — Supporting BRS1.
- Depends on methylation efficiency interacting with omega-3 status for full effect.
2. Primary Biological Effects
↑ phosphatidylcholine formation; ↑ membrane fluidity; ↑ receptor signaling stability
3. Phenome Connections
These outcomes describe translational contexts for the FM as an integrated biological capacity. They are not single-mechanism treatment claims. Biology → Phenome Confidence reflects biological relevance to each outcome — not proof that diet or lifestyle alone will improve it. Evidence Confidence (below Key References) reflects how convincing the attached evidence is for the Biology → Phenome relationship on that row. FM confidence uplift: FM confidence may exceed that of any individual child PM only where multiple PMs converge on the same phenome and the integrated FM biology provides additional biological rationale (biological uplift) beyond the individual mechanisms.
These are three independent scores. They are not combined or averaged. A phenome can have Medium registry evidence while individual mechanism rows show different Biology → Phenome and Evidence scores.
1. Phenome Evidence Confidence (Phenome Registry only)
Question: How convincing is the foundational evidence that this phenome is a valid, well-defined functional construct — and that diet-relevant biology can plausibly connect to it?
Not a roll-up of Biology → Phenome Confidence or Evidence Confidence from Primary Mechanism page rows. Those are scored per mechanism; this score is assigned once per phenome at registry level.
Derived from foundational landmark evidence organised in up to three layers: construct validation, biology→phenome linkage, and nutrition→biology modulation. Each layer may include one or many landmark papers depending on registry review.
2. Biology → Phenome Confidence (Primary Mechanism page §3 rows)
Question: If this PM/FM biology were substantially impaired in isolation, how directly would that phenome be expected to suffer — within BRAIN architecture?
How it is derived: Reviewers read the PM/FM definition and biological function first — initially ignoring attached references and whether dietary intervention studies exist. References are reviewed only when scoring Evidence Confidence (below).
Score levels (the value shown on each row as Biology → Phenome Confidence):
- High — primary biological determinant (e.g. noradrenergic signalling → attention; GABA synthesis → calming tone)
- Medium — major contributory determinant, not the sole driver
- Low–Medium — established but indirect, modulatory, or one integrative step removed
- Low — distal, conditional, or weak biological coupling
“Not dietary treatment efficacy” means this score does not ask whether a diet or supplement treats the phenome. It asks whether the biology itself is architecturally relevant. Limited dietary RCT evidence belongs in Evidence Confidence, not here.
3. Evidence Confidence (Primary Mechanism page §3 rows)
Question: How convincing are the attached Key References on that specific row that this biology actually relates to this phenome?
How it is derived: Assigned after Biology → Phenome Confidence, by reviewing only the references on that PM/FM row. Judges whether refs support the relationship — not just mechanism or phenome in isolation.
- High — strong convergent human evidence directly linking mechanism biology to phenome variation
- Medium — multiple human lines supporting the relationship; may include one bridge study with an inferential step
- Low–Medium — convergent translational stack without direct mechanism↔phenome measurement on the row
- Low — mechanistic or preclinical only; mechanism and phenome supported separately but not bridged
Often equal to or lower than Biology → Phenome Confidence. Can occasionally be higher when outcome evidence is stronger than the mechanism's contributory role.
- Biology → Phenome Confidence: Medium
- Synthesis: SAMe-dependent phosphatidylcholine formation couples one-carbon methylation to membrane phospholipid chemistry — the methylation-dependent bridge between B-vitamin status and omega-3-enriched PC delivery toward the brain. VITACOG reanalysis, PEMT pathway biology, and phospholipid-bound DHA accretion evidence support cognitive-clarity framework translation; ADHD-specific cognitive-clarity trials on this FM remain limited.
- Key References:
- Evidence Confidence: Low–Medium
- Biology → Phenome Confidence: Low–Medium
- Synthesis: Methylation–membrane coupling links dietary methyl-donor and omega-3 patterns associated with reduced ADHD symptoms to phosphatidylcholine formation as the carrier chemistry supporting long-chain PUFA presentation. Choline implicated across neurodevelopmental disorders reinforces attention-relevant nutrient-pattern context — scope is PC formation biology, not isolated choline supplementation efficacy.
- Key References:
- Evidence Confidence: Low–Medium
4. Mechanistic Basis (Integrated FM Narrative)
Methylation–membrane coupling represents a framework-relevant biological state anchored principally by its sole primary mechanism.
4.1 Core Primary Mechanisms
- BRS2-FM3-PM7 — Phosphatidylcholine Formation Helps build phospholipid membranes that carry omega-3 fatty acids toward the brain, supporting membrane flexibility and cell signalling.
4.2 Integrated Functional Narrative
Together, SAMe synthesis and phosphatidylcholine formation operationalise BRS2(FM3) as the methylation–membrane coupling bridge between one-carbon metabolism and neuronal membrane chemistry.
At the integrated FM level, SAMe-dependent phosphatidylethanolamine methylation shapes phosphatidylcholine pools that influence membrane composition, choline carriage, and omega-3 integration context—connecting B-vitamin and methyl-donor status to the membrane environment the brain relies on [Vance et al., 2014; Oulhaj et al., 2016].
4.3 Suboptimal Function & Its Effects
Methylation–membrane coupling may weaken when one-carbon donor pools or methionine substrate pools become chronically inadequate.
Low intake of methyl-donor-rich foods may reduce BRS2(KC1) — One-Carbon Donor Pool. Poor dietary choline availability, low folate availability, and increased methylation demand may limit SAMe generation for phosphatidylcholine formation.
Low protein quality or insufficient sulfur-amino-acid intake may reduce BRS2(KC2) — Methionine & Transsulfuration Substrate Pool, further constraining methionine-cycle throughput available to SAMe synthesis.
These pressures may impair BRS2-FM1-PM3 — SAMe Synthesis and weaken BRS2-FM3-PM7 — Phosphatidylcholine Formation. At the FM level, this may shift BRS2(FM3) toward reduced methylation–membrane coupling—with downstream relevance to neuronal membrane chemistry in BRS1 [Vance et al., 2014].
4.4 Evidence Highlights
Introduction/Summary
The evidence below supports why methylation–membrane coupling matters as an integrated FM state — mechanism-qualifying findings from child PM biology, not functional outcome or phenome claims.
- Confidence: low-medium
- Evidence Level: mechanistic
- Rationale: Re-analysis of VITACOG trial data showed that B vitamin supplementation slowed cognitive decline only in participants with adequate omega-3 status; when baseline omega-3 concentrations were low, B vitamins had no effect on cognitive decline in mild cognitive impairment → [Oulhaj et al., 2016] Docosahexaenoic acid concentrations particularly enhanced the cognitive effects of B vitamins, while eicosapentaenoic acid appeared less effective in this interaction. This finding supports reading phospholipid methylation not in isolation but as part of a nutrient-synergy model linking one-carbon metabolism to membrane omega-3 carriage.
- Key References:
- Confidence: low-medium
- Evidence Level: mechanistic
- Rationale: In the same analytical frame, Oulhaj et al. propose that B vitamins support the formation of omega-3-enriched phosphatidylcholine from phosphatidylethanolamine — coupling homocysteine/methylation regulation to the phospholipid pool that delivers long-chain PUFA toward the brain: "B vitamins facilitate the formation of phosphatidylcholine (PC) enriched in omega-3 fatty acids from phosphatidylethanolamine (Fig. 5) and hence the transport of omega-3 fatty acids into the brain" — Abderrahim Oulhaj [Oulhaj et al., 2016] This positions BRS2-FM3-PM7 as the methylation-dependent bridge between upstream one-carbon support and downstream brain omega-3 delivery represented in BRS1-FM3-PM6.
- Key References:
- Confidence: low-medium
- Evidence Level: mechanistic
- Rationale: In neonatal piglets, dietary DHA provided as phospholipid was approximately 1.9-fold more efficacious than triglyceride-DHA for supplying DHA to cerebral cortex — the strongest direct brain-tissue accretion evidence for PC as a carrier form, though species and developmental context limit direct human extrapolation → [Liu et al., 2014] The principal human randomised evidence for central DHA delivery — Arellanes et al. — measured DHA enrichment in cerebrospinal fluid rather than brain tissue accretion, so it supports central compartment delivery interpretation without proving comparable tissue incorporation rates across individuals → [Arellanes et al., 2020]
- Key References:
5. Connected Mechanisms
- BRS1-FM3-PM6 — Neuronal Membrane DHA Incorporation — neuronal Membrane DHA Incorporation
- BRS2-FM1-PM1 — Folate/B12-Dependent Homocysteine Remethylation — Upstream homocysteine remethylation, methionine flux,
- BRS2-FM1-PM3 — SAMe Synthesis — sAMe Synthesis
6. References
- Vance et al. (2014) — Physiological Roles of Phosphatidylethanolamine N-methyltransferase
- Arellanes et al. (2020) — A Randomized Placebo-controlled Clinical Trial
- Oulhaj et al. (2016) — Omega-3 Fatty Acid Status Enhances the Prevention of Cognitive Decline by B
- Liu et al. (2014) — Higher Efficacy of Dietary DHA Provided As a Phospholipid Than As a
- Millichap and Yee (2012) — Diet Factor in Attention-Deficit/Hyperactivity Disorder
- Derbyshire and Maes (2023) — Role of Choline in Neurodevelopmental Disorders